Physiologically active derivatives of esterastin
    21.
    发明授权
    Physiologically active derivatives of esterastin 失效
    酯酶的生理活性衍生物

    公开(公告)号:US4202824A

    公开(公告)日:1980-05-13

    申请号:US033359

    申请日:1979-04-26

    IPC分类号: C07D305/12 C12P17/02

    摘要: Three, new physiologically active derivatives of esterastin are now provided, which inhibit the activity of esterase similarly to the parent esterastin and further exhibit a higher inhibiting activity against cholesterol esterase than the parent esterastin. These three new derivatives are tetrahydroesterastin which is produced by catalytic hydrogenation of esterastin; 3,5-di-hydroxy-2-hexylhexadeca-7,10-dienoic 1,3-lactone which is produced by alkaline hydrolysis of esterastin; and 3,5-di-hydroxy-2-hexylhexadecanoic 1,3-lactone which is produced either by alkaline hydrolysis of said tetrahydroesterastin or by catalytic hydrogenation of the product of the alkaline hydrolysis of esterastin.

    摘要翻译: 现在提供三种酯活性的新的生理活性衍生物,其类似于母体酯酶抑制酯酶的活性,并且进一步表现出比母体酯酶更高的对胆固醇酯酶的抑制活性。 这三种新的衍生物是通过酯酶的催化氢化制备的四氢西菌素 3,5-二羟基-2-己基十六碳-7,10-二烯-1,3-内酯,其通过酯酶抑制剂的碱性水解产生; 和3,5-二羟基-2-己基十六烷酸1,3-内酯,其通过所述四氢壳聚糖的碱水解或通过催化氢化酯酶的碱性水解产生。